Notably, the tumor-suppressing effects of GPD2 and mitochondrial GPX4 against ferroptosis are additive, highlighting the contribution of GPD2 in mitochondrial ferroptosis resistance [139]. The gene discussed is GPD2; the disease is neoplasm.